Dermapharm Holding SE buy DirectorDealer
Start price
23.11.23
/
50%
€40.38
Target price
23.11.24
-
Performance (%)
-22.11%
Price
26.04.24
€31.45
Summary
This prediction is currently active. The price of Dermapharm Holding SE has decreased since the start of the prediction. Compared to the start price this results in a performance of -22.11%. This prediction currently runs until 23.11.24. The prediction end date can be changed by DirectorDealer at any time. DirectorDealer has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Dermapharm Holding SE | -2.025% | -2.025% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by DirectorDealer for this prediction
In the thread Dermapharm Holding SE diskutieren
Director's Dealing / Insider Kauf von Themis Beteiligungs-Aktiengesellschaft (in enger Beziehung)
- Handelstag: 21.11.2023
- Volumen: 15216000 €
- Meldende_r: Themis Beteiligungs-Aktiengesellschaft